Kyntra Bio EBIT (Quarterly) Analysis

Kyntra Bio, Inc. (KYNB)

8.74 +0.19 (+2.22%) USD | NASDAQ | Jan 21, 16:00

8.83 +0.09 (+1.03%) Pre-Market: 20:00

View EBIT (Quarterly) for KYNB.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EBIT (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EBIT Definition

Start Trial

EBIT is an acronym for earnings before interest and taxes.

View EBIT (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EBIT (Quarterly) Benchmarks

Start Trial

Assertio Holdings, Inc.	Upgrade
Perspective Therapeutics, Inc.	Upgrade
Skye Bioscience, Inc.	Upgrade
Theravance Biopharma, Inc.	Upgrade
Myomo, Inc.	Upgrade